anesthesia and semaglutide Your patient took this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual gastric volume was higher when GLP-1/GIP agonists were continued vs held for GLP-1 semaglutide anesthesia endoscopy

This creates a vicious cycle where metabolic dysfunction perpetuates further insulin resistance

However, similar to the recommendations for women, healthcare providers might suggest that men discuss with their doctors if they plan to conceive

Neutral flavor keeps things simple in long efforts where taste fatigue tanks your intake

Mechanistic support primarily comes from cellular and animal studies, which demonstrate that EGT protects endothelial cells from oxidative stress and may limit ischemiareperfusion damage and vascular dysfunction, rather than from large-scale human intervention trials

The gastrointestinal side effect profile was consistent with the GLP-1 agonist class: Nausea (most common, generally transient) Vomiting Diarrhea Decreased appetite Constipation These adverse events were described as generally mild and infrequently led to treatment discontinuation